E-LIB Suche - Ergebnisse für: Pressiani, T.

1

Comparative analysis of subclassification models in patient..:

Ielasi, L. ; Stefanini, B. ; Conti, F....
Digestive and Liver Disease. 56 (2024) - p. S85 , 2024

Link: https://doi.org/10.1016/..

2

Immunosuppressive contribution of tumor-infiltrating B cell..:

Milardi, G. ; Franceschini, B. ; Camisaschi, C....
Digestive and Liver Disease. 56 (2024) - p. S94-S95 , 2024

Link: https://doi.org/10.1016/..

3

Identification of factors associated with primary refractor..:

Manfredi, G.F. ; Fulgenzi, C.A.M. ; D'Alessio, A....
Digestive and Liver Disease. 56 (2024) - p. S8-S9 , 2024

Link: https://doi.org/10.1016/..

4

Prognostic impact of metastatic site in patients receiving ..:

Ielasi, L. ; Tovoli, F. ; Stefanini, B....
Digestive and Liver Disease. 55 (2023) - p. S42 , 2023

Link: https://doi.org/10.1016/..

5

Prognostic impact of previous intraarterial treatment in pa..:

Stefanini, B. ; Ielasi, L. ; Pressiani, T....
Digestive and Liver Disease. 55 (2023) - p. S54-S55 , 2023

Link: https://doi.org/10.1016/..

6

Clinical impact of relative dose intensity of cabozantinib ..:

Tovoli, F. ; Dadduzio, V. ; De Lorenzo, S....
Digestive and Liver Disease. 55 (2023) - p. S224-S225 , 2023

Link: https://doi.org/10.1016/..

7

Atezolizumab plus bevacizumab versus lenvatinib or sorafeni..:

Rimini, M. ; Rimassa, L. ; Ueshima, K....
ESMO Open. 7 (2022) 6 - p. 100591 , 2022

Link: https://doi.org/10.1016/..

8

Real-life clinical data of cabozantinib for unresectable he..:

Tovoli, F. ; Dadduzio, V. ; De Lorenzo, S....
Digestive and Liver Disease. 53 (2021) - p. S10 , 2021

Link: https://doi.org/10.1016/..

9

Prognostication of hepatocellular carcinoma under sorafenib..:

Sansone, V. ; Tovoli, F. ; Casadei-Gardini, A....
Digestive and Liver Disease. 52 (2020) - p. e15 , 2020

Link: https://doi.org/10.1016/..

10

PO-0811 SBRT compared to sorafenib in locally advanced hepa..:

Gkika, E. ; Brunner, T. ; Abbasi-Senger, N....
Radiotherapy and Oncology. 133 (2019) - p. S423 , 2019

Link: https://doi.org/10.1016/..

11

Risk-stratified management of advanced hepatocellular carci..:

Pinato, D.J. ; Kaplan, D.E. ; Yen, C....
Journal of Hepatology. 68 (2018) - p. S196 , 2018

Link: https://doi.org/10.1016/..

12

Prognostic scores for sorafenib-treated hepatocellular carc..:

Tovoli, F. ; Costanzo, G.G.D. ; Magini, G....
Journal of Hepatology. 68 (2018) - p. S436-S437 , 2018

Link: https://doi.org/10.1016/..

13

Treatment-stage migration maximizes survival outcomes in pa..:

Yen, C. ; Sharma, R. ; Rimassa, L....
Journal of Hepatology. 66 (2017) 1 - p. S223-S224 , 2017

Link: https://doi.org/10.1016/..

14

6617 Phase II study of NGR-hTNF, a selective vascular targe..:

Santoro, A. ; Citterio, G. ; Pressiani, T....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 395 , 2009

Link: https://doi.org/10.1016/..

15

6616 Serial alpha-fetoprotein evaluation and survival in he..:

Personeni, N. ; Bozzarelli, S. ; Giordano, L....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 394-395 , 2009

Link: https://doi.org/10.1016/..